Russia begins post-registration trials of EpiVacCorona Covid-19 vaccine

EpiVacCorona is developed by the Vector State Research Center of Virology and Biotechnology Credit: Dimitri Houtteman on Unsplash.



  • Russia; EpiVacCorona